Skinvisible (SKVI) Equity Average (2016 - 2025)
Skinvisible (SKVI) has disclosed Equity Average for 15 consecutive years, with -$10.1 million as the latest value for Q4 2025.
- Quarterly Equity Average fell 6.16% to -$10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.1 million through Dec 2025, down 6.16% year-over-year, with the annual reading at -$9.7 million for FY2025, 6.79% down from the prior year.
- Equity Average hit -$10.1 million in Q4 2025 for Skinvisible, down from -$9.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of -$4.7 million in Q1 2021 to a low of -$10.1 million in Q4 2025.
- Historically, Equity Average has averaged -$7.7 million across 5 years, with a median of -$8.4 million in 2023.
- Biggest five-year swings in Equity Average: crashed 45.01% in 2021 and later fell 1.59% in 2025.
- Year by year, Equity Average stood at -$5.4 million in 2021, then fell by 20.1% to -$6.4 million in 2022, then crashed by 37.74% to -$8.9 million in 2023, then dropped by 7.6% to -$9.5 million in 2024, then fell by 6.16% to -$10.1 million in 2025.
- Business Quant data shows Equity Average for SKVI at -$10.1 million in Q4 2025, -$9.9 million in Q3 2025, and -$9.6 million in Q2 2025.